The ACO REACH versus MSSP decision has never been a simple comparison of payment models. It is a decision about how much insurance risk an organization can actually manage, how much capital it can commit, and whether its operating model is mature enough to influence total cost of care rather than merely report on it. More on both models: ACO REACH vs. MSSP explained
For provider organizations, the distinction is material. Medicare Shared Savings Program participation can be an on-ramp to accountable care, particularly for organizations building population health capabilities. ACO REACH was designed for entities prepared to accept substantially greater accountability, including downside risk and more direct payment mechanisms. But the timing now matters as much as the structure: CMS has said the ACO REACH Model will conclude after the 2026 performance year, with the ACCESS Model scheduled to begin in 2027.
That makes 2026 less of a theoretical debate and more of a strategic transition year. Organizations should be deciding what they learned from ACO REACH, what risk capabilities they have built, and where they fit in Medicare’s next generation of value-based care. More on ACO’s and Medicare policy here: https://rhislop3.com/unlocking-the-potential-overcoming-challenges-for-ltpac-providers-in-aco-participation/
ACO REACH versus MSSP: Different Risk Philosophies
MSSP is Medicare’s core permanent accountable care program. It allows ACOs to share in savings when they outperform a benchmark while meeting quality requirements. Depending on the track and level selected, participants may have limited or no downside risk early on, or may take on progressively greater downside exposure. The ENHANCED track carries the most meaningful financial accountability, but MSSP still gives organizations a structured pathway to build experience.
ACO REACH was not built as a cautious entry point. It is the successor to the GPDC model (Global and Professional Direct Contracting). The Primary option placed participants at 50 percent shared savings and shared losses, while its Global option required 100 percent accountability for total cost of care. Those arrangements demand much more than an analytics platform and a care-management vendor. They require disciplined network management, credible utilization controls, strong primary care relationships, and the financial capacity to absorb adverse performance.
The practical difference is straightforward: MSSP permits more gradual progression into risk. ACO REACH required an organization to demonstrate that it could operate as a population-based enterprise.
That distinction is especially relevant for senior living, post-acute, home health, hospice, and physician organizations. These sectors often see the consequences of fragmented Medicare care first: preventable hospitalizations, poor transitions, medication errors, delayed follow-up, avoidable emergency department use, and inadequate support for medically complex older adults. Yet seeing those failures is not the same as having the authority, data, contracts, and capital to correct them at scale.
Capitation Changes the Operating Model
One of ACO REACH’s most consequential features was its ability to support more prospective, population-based payment approaches. Under the Professional option, participating ACOs could use primary care capitation. Under Global, they could elect primary care capitation or total care capitation. These mechanisms were intended to move participating organizations away from fee-for-service incentives and toward proactive care delivery.
That matters because fee-for-service reimbursement still rewards activity more reliably than prevention. A practice paid visit by visit has little financial room to deploy community health workers, intensive transition teams, behavioral health support, or home-based interventions unless another payment stream supports the work. Capitated payments can fund that infrastructure before an acute event occurs.
MSSP, by comparison, generally maintains fee-for-service claims payment during the performance year, with shared savings or losses reconciled later. That structure is easier for many organizations to understand and enter, but it can weaken the immediate operating signal. Leaders may endorse value-based care while their front-line economics remain tied to volume.
This is not an argument that capitation is automatically superior. Capitation transfers financial responsibility before it guarantees operational competence. Poorly calibrated payments, weak clinical networks, and inadequate beneficiary engagement can turn prospective payment into an accelerated loss. The point is that the payment method must match the organization’s ability to manage utilization and quality.
Equity and Governance Were More Central in REACH
ACO REACH was developed in response to criticism that prior direct contracting initiatives could enable favorable selection or place financial intermediaries too far from patient care. CMS incorporated health equity requirements, participant governance expectations, and stronger oversight provisions intended to keep the model anchored in beneficiaries and providers.
For operators, this was not merely a compliance exercise. It forced a more serious conversation about who is being served, which populations carry the greatest unmet need, and whether the ACO has the local relationships necessary to address nonclinical barriers to care. For older adults, those barriers often include transportation, food insecurity, caregiver limitations, housing instability, cognitive decline, and the absence of primary care access after discharge.
MSSP has also advanced health equity requirements and quality reporting expectations. But ACO REACH made equity a more visible component of its identity and model design. That created both opportunity and friction. Organizations with authentic community presence could differentiate themselves. Organizations treating equity as an administrative workstream quickly discovered that reporting requirements do not substitute for trusted care relationships.
Senior care providers should take that lesson seriously. A discharge partnership, an admissions pipeline, or a referral relationship does not create population health capability. The organizations positioned to succeed in advanced risk models will be those that can demonstrate closed-loop transitions, shared clinical information, physician alignment, and measurable reductions in avoidable utilization.
MSSP Offers a More Durable Pathway
The most significant strategic fact in this comparison is permanence. MSSP is embedded in Medicare and remains the principal platform for organizations seeking a durable accountable care strategy. ACO REACH was an Innovation Center model with a defined endpoint. Its pending conclusion does not negate the operational achievements of participating organizations, but it does limit the wisdom of treating REACH as a long-term standalone destination.
CMS’s planned ACCESS Model will carry forward the broader policy direction: greater accountability for total cost of care, attention to underserved beneficiaries, and increased use of flexible payment tools. Organizations evaluating their next move should not assume ACCESS will be ACO REACH under a different label. New participation rules, financial methodologies, and operational expectations can alter the economics materially.
For many providers, the sensible path is MSSP participation with a deliberate plan to progress toward two-sided risk. That is not a retreat from value-based care. It is a recognition that downside risk should be earned through demonstrated capabilities, not adopted because the market has declared risk contracting inevitable.
Organizations that have already operated successfully in ACO REACH may have a different calculation. They should preserve the assets that made advanced risk possible: timely claims data, physician engagement, preferred post-acute relationships, home-based care capacity, actuarial discipline, and a governance structure capable of making difficult utilization decisions. Those capabilities will be relevant regardless of the model name attached to them.
The Financial Question Is Not Just Benchmark Performance
Too many board discussions reduce accountable care to one question: can the organization generate shared savings? That is necessary, but it is not sufficient. An ACO can produce a favorable year because of benchmark dynamics, regional spending trends, coding changes, or favorable attribution patterns. Sustainable performance requires a more demanding assessment.
Can the organization identify rising-risk beneficiaries early? Can it manage the transition from hospital to skilled nursing, home health, assisted living, or home without avoidable leakage and readmissions? Can it engage independent physicians who remain economically oriented around fee-for-service volume? Can it withstand a year in which high-cost cases arrive faster than projected?
Capital deserves equal attention. Under substantial downside risk, reserves are not a finance department technicality. They are the difference between a strategic investment and an enterprise-threatening exposure. This is particularly true for organizations with thin margins, high labor costs, or debt structures already stressed by occupancy recovery and reimbursement pressure.
There is also a governance question. ACO decisions frequently involve competing interests among physicians, hospitals, post-acute providers, management companies, and investors. The more risk an organization accepts, the less room it has for ambiguous authority. Someone must be accountable for network decisions, care-management investments, referral strategy, and performance remediation.
What Leaders Should Do Before 2027
The right response to the ACO REACH transition is not to wait for final ACCESS details and then scramble. Leadership teams should use the remaining period to conduct an honest risk-readiness assessment. Review performance by beneficiary cohort, not only total financial results. Separate favorable benchmark effects from utilization changes the organization can credibly sustain. Test whether care-management interventions are producing measurable reductions in acute utilization and whether those results can survive changes in attribution or payment methodology.
They should also examine their post-acute strategy. Medicare spending cannot be managed effectively when hospitals, skilled nursing facilities, home health agencies, primary care practices, and community-based services operate as disconnected vendors. For medically complex older adults, the handoff is often the intervention. Organizations that control or coordinate those handoffs will have a material advantage under any serious total-cost-of-care model.
The ACO REACH versus MSSP debate should therefore be treated as a capability question, not a branding exercise. MSSP remains the durable foundation. Advanced models reward organizations that can convert clinical coordination into financial accountability without compromising access or quality. As CMS moves toward ACCESS, the winners will not be the organizations that embraced risk most loudly. They will be the ones that built the discipline to carry it.
